During the past decade, Arizona Heart Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arizona Heart Institute" #1 sponsor was "Arizona Heart Institute" with 8 trials, followed by "Boston Scientific Corporation" with 3 trials sponsored, "Bolton Medical" with 2 trials sponsored, "Endologix" with 2 trials sponsored and "Vericel Corporation" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arizona Heart Institute" #1 collaborator was "Endologix" with 1 trials as a collaborator, "MED Institute, Incorporated" with 1 trials as a collaborator, "Orion Corporation, Orion Pharma" with 1 trials as a collaborator, "Vascutek Ltd." with 1 trials as a collaborator and "Volcano Corporation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Arizona Heart Institute" are "Peripheral Arterial Disease" (4 trials), "Peripheral Vascular Disease" (4 trials), "Abdominal Aortic Aneurysm" (3 trials), "Congestive Heart Failure" (3 trials) and "Aneurysm" (2 trials). Many other conditions were trialed in "Arizona Heart Institute" in a lesser frequency.

Most popular intervention types in "Arizona Heart Institute" are "Device" (24 trials), "Procedure" (6 trials), "Biological" (5 trials), "Drug" (3 trials) and "Genetic" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Ixmyelocel-T" (2 trials), "Anaconda ONE-LOK Stent Graft System" (1 trials), "Anaconda Stent Graft System" (1 trials) and "Angioplasty/Stent (Guidant "Absolute" stent)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arizona Heart Institute" are 36 trials for "All" genders.

Currently, there are NaN active trials in "Arizona Heart Institute". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Arizona Heart Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Arizona Heart Institute, 4 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 15 trials that are defined as “Not Applicable".

Arizona Heart Institute has several departments that took part in Clinical trials: "Michael Morgan, MD" - 2 trials